Baudax Stock Today

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>BB</div>
Baudax Bio is trading at 4.25 as of the 31st of May 2020; that is -3.19 percent down since the beginning of the trading day. The stock's open price was 4.39. Baudax Bio has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 30 trading days. Equity ratings for Baudax Bio are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 2nd of March 2020 and ending today, the 31st of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance7 100 

Baudax Bio Profile

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 24 people. more on Baudax Bio
Legal NameBaudax Bio
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Baudax Bio available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Baudax Bio (BXRX) is traded on BATS Exchange in USA and employs 24 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 70.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Baudax Bio's market, we take the total number of it shares issued and multiply it by the Baudax Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Baudax Bio conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 17.57 M outstanding shares of which 1.9 M shares are currently shorted by private and institutional investors with about 2.12 trading days to cover. The company currently holds about 38.28 M in cash with (41.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.18.
Check Baudax Bio Probability Of Bankruptcy

Ownership Allocation (%)

Baudax Stock Price Odds Analysis

Odds Down 4.25HorizonTargetOdds Up 4.25
64.85%30 days
 4.25 
35.08%
Based on normal probability distribution, the odds of Baudax Bio to move above current price in 30 days from now is about 35.08 (This Baudax Bio probability density function shows the probability of Baudax Bio Stock to fall within a particular range of prices over 30 days) .

Baudax Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
North Run Capital LpCommon Shares1.2 M2.9 M
Corsair Capital Management LpCommon Shares880.3 K2.2 M
Alyeska Investment Group LpCall Options815.4 KM
View Baudax Bio Diagnostics

Baudax Bio Risk Profiles

Baudax Stock Against Markets

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module
Continue to Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page